'+
'| • '+heading+' |
| '+
''+
' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('| 4/25 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies Reports First Quarter Results | \n'); } if (allow) { document.write('
| 4/24 - 3:01 AM \; \; | \n'); } if (allow) { document.write('CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI®\; (sparsentan) for the treatment of IgA Nephropathy | \n'); } if (allow) { document.write('
| 4/11 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies to Announce First Quarter 2024 Results on April 25, 2024 | \n'); } if (allow) { document.write('
| 4/4 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Armstrong World Industries Names Dawn Kirchner-King as SVP, Chief Human Resources Officer | \n'); } if (allow) { document.write('
| 3/19 - 7:01 AM \; \; | \n'); } if (allow) { document.write('Ferinject®\; approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure | \n'); } if (allow) { document.write('
| 3/18 - 6:47 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies to Acquire MTL Holdings, a Leader in Edge Metal and Non-Insulated Architectural Wall Systems | \n'); } if (allow) { document.write('
| 3/6 - 9:01 AM \; \; | \n'); } if (allow) { document.write('CSL Seqirus is Fully Prepared to Implement the FDA\'s Vaccines and Related Biological Products Advisory Committee Trivalent Influenza Vaccines Strain Selection for the 2024/25 U.S. Season | \n'); } if (allow) { document.write('
| 2/12 - 10:56 PM \; \; | \n'); } if (allow) { document.write('Half year reported NPATA US$2 billion¹\;,²\; Up 13% at constant currency³\; | \n'); } if (allow) { document.write('
| 2/11 - 5:48 PM \; \; | \n'); } if (allow) { document.write('CSL Announces Top-line Results from the Phase 3 AEGIS-II Trial Evaluating the Efficacy and Safety of CSL112 (apolipoprotein A-I [human]) | \n'); } if (allow) { document.write('
| 2/6 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies Reports Fourth Quarter Results | \n'); } if (allow) { document.write('
| 2/5 - 8:31 AM \; \; | \n'); } if (allow) { document.write('New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster | \n'); } if (allow) { document.write('
| 2/1 - 3:15 PM \; \; | \n'); } if (allow) { document.write('Carlisle Receives First-Ever LEED Platinum v4 Certification in North America | \n'); } if (allow) { document.write('
| 1/30 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies Declares Regular Quarterly Dividend | \n'); } if (allow) { document.write('
| 1/30 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Amphenol Corporation to Acquire CIT Business From Carlisle | \n'); } if (allow) { document.write('
| 1/30 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Carlisle Companies Signs Definitive Agreement to Sell Carlisle Interconnect Technologies to Complete its Pivot to a Pure Play Building Products Company | \n'); } if (allow) { document.write('
| 1/23 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Carlisle Companies to Announce Fourth Quarter 2023 Results on February 6, 2024 | \n'); } if (allow) { document.write('
| 1/16 - 8:01 AM \; \; | \n'); } if (allow) { document.write('Harris Poll Survey Finds People Receiving Treatment for CIDP Are Interested in Exploring More Convenient Treatment Options | \n'); } if (allow) { document.write('
| 1/3 - 8:01 AM \; \; | \n'); } if (allow) { document.write('CSL Behring Announces Availability of Hizentra®\; (Immune Globulin Subcutaneous [Human] 20% Liquid) 10g Prefilled Syringe | \n'); } if (allow) { document.write('
 | |
| \n'); } if (allow) { document.write(' | |
If you reached this page'+
' after attempting to place a TickerTech.com product onto your web page, go no further; you must sign up as a'+
' paying client. For pricing information please visit our products page, email '+
' services@tickertech.com, or give us a call at 1-866-515-2082.'+
' '+
'